Empresa y Finanzas

Galenica Reports 4.8% Sales Growth In 2024
Galenica sees robust sales growth across all sectors, driven by strong pharmaceutical market.
Julius Baer Net New Money Growth Slows
Julius Baer attracts less new money in early 2024, but assets under management rise.
Swiss Corporate Tax Rates Remain Low Amid Global Shifts
Switzerland maintains competitive corporate tax rates, but faces new challenges from global tax policies.
Comet Shares Soar on Analyst’s Buy Recommendation
Comet's shares surge as analysts see bright future in semiconductor market and ai.
Swiss Steel Industry Relies On Subsidies: Job Cuts
Federal council supports Swiss steel industry with current and future measures, for now.
Swiss Insurance To Rise To 6% By 2025: Comparis
Comparis forecasts six percent rise in 2025; some regions to see over 10% hike. KEYSTONE/Christian Beutler The comparison portal Comparis has forecast an average increase in basic insurance premiums of six percent for 2025.
“Do Not Fear Trade Dependency” – Federal Council
Federal council report reveals manageable trade dependencies for Switzerland amid geopolitical tensions.
New Swiss Cloud Infrastructure For CHF 320 Million
The Swiss government proposes a 320 million francs investment in the "Swiss Government Cloud" to advance digital transformation, with Parliament deciding on a CHF 247 million commitment credit.
Swiss Transparency Register to Combat Money Laundering
The Swiss Federal Council seeks to enhance the fight against money laundering with a new national transparency register and extended due diligence obligations for lawyers.
Swiss Banking Ombudsman Sees Rise in Cases Due to Losses & Fraud
The Swiss Banking Ombudsman handled more cases in 2023, driven by 2022 investment losses, increased fraud, and the CS crisis.
Swiss Life Insurance Group Starts Q1 2024 Strong
Swiss Life sees 8% rise in fee business in Q1 2024, maintains premium income, and remains on track with annual goals.
Swiss Tech Industry Faces Challenges
Swiss tech industry struggles with declining sales and exports, but stabilization signs offer hope for recovery in 2024.
Swixx BioPharma Expands into Latin America: Biopas Merger
Swixx BioPharma significantly expands its market reach in Latin America by acquiring Biopas, enhancing its presence in neurology, oncology, and other therapeutic areas.
Zurich Kunsthaus Faces Financial Challenges Amid Rising Deficit
Zurich Kunsthaus struggles with growing financial deficit, contemplating subsidy increases and higher ticket prices.
Jean-Paul Clozel Steps Down as Idorsia CEO
ean-Paul Clozel hands over Idorsia's CEO role to André Muller amid financial challenges, aiming for a turnaround.
Migros Announces 150 Job Cuts Amid Restructuring
Migros Supermarkt AG informs employees of 150 job cuts as part of a major reorganization aimed at streamlining operations.
Cevian’s Investment in Baloise: Over 3% Stake Revealed
Cevian Capital, a Swedish activist investor, now owns more than 3% of Swiss insurance group Baloise, intensifying market speculation and scrutiny.
Swiss Trade Barriers Costing Millions: EU Agreement Coming
The Switzerland-EU agreement streamlines product export and import, preventing multimillion-franc costs for Swiss businesses.

Historias relacionadas

Mantente en contacto

Cabe destacar

the swiss times
Una producción de UltraSwiss AG, 6340 Baar, Suiza
Copyright © 2024 UltraSwiss AG 2024 Todos los derechos reservados